Section VI - Public Information and Communication - WORD

L1. Section VI_Public Information and Communication.doc

Information Collections to Advance State, Tribal, Local and Territorial (STLT) Governmental Agency System Performance, Capacity, and Program Delivery

Section VI - Public Information and Communication - WORD

OMB: 0920-0879

Document [doc]
Download: doc | pdf

Attachment L1 Section VI: Public Information and Communication_TEST - Final


Form Approved

OMB Number: 0920-0879

Expiration Date: 03/31/2018


Introduction

Background
The 2009 H1N1 influenza pandemic underscored the importance of communities being prepared for potential threats to public health security. Because of its unique abilities to respond to infectious, occupational, or environmental incidents, the Centers for Disease Control and Prevention (CDC) plays a pivotal role in ensuring that state and local public health systems are prepared for these and other public health incidents.  

The identification of the novel influenza A (H7N9) virus illnesses in China in 2013 highlights the importance of influenza pandemic preparedness. To date, the reported case fatality ratio from human H7N9 infections is more than 30%. Should the H7N9 virus mutate to allow for sustained human-to-human transmission, it appears capable of causing severe disease in all ages. To better prepare for such a scenario, it is important to   understand the collective ability of our nation to prepare for and respond to a pandemic of substantially different epidemiology than the 2009 H1N1 pandemic.  

State and local public health departments are first responders for public health incidents. To better prepare these agencies to respond, CDC provides funding and technical assistance for state, local, and territorial public health departments through the Public Health Emergency Preparedness (PHEP) cooperative agreement.  CDC’s Public Health Preparedness Capabilities: National Standards for State and Local Planning provide national standards that help state and local public health departments strengthen their ability to respond to all hazards, including influenza pandemics, and build more resilient communities.  Consistent with this approach, the following Pandemic Preparedness Readiness Assessment for State and Local Public Health Planners specifically aligns with 11 public health preparedness capabilities and administrative preparedness planning goals.  

Overview
The Pandemic Preparedness Readiness Assessment for State and Local Public Health Planners promotes state, local, and territorial public health preparedness and immunization program collaboration through the administration of a self-assessment designed to measure jurisdictional readiness to respond to an influenza pandemic.  Although the content of this assessment does not encompass every contingency or element necessary to effectively respond to an influenza pandemic, CDC technical experts in differing programs have helped to arrange content within the following seven priority planning areas:  

1.         Vaccination Planning
2.         Epidemiology and laboratory
3.         Medical Care and Countermeasures
4.         Healthcare Systems
5.         Community Mitigation
6.         Public Information and Communication
7.         Public Health and Immunization Workforce  

Information collected from the assessment will not be used to score or competitively rank public health emergency preparedness or immunization programs.  Rather, this assessment is designed to identify preparedness gaps, as well as promising state, local, and territorial preparedness practices. Assessment results will be used by the CDC to inform technical assistance and future program improvement initiatives.      

Definitions  

Allocation: Amount of pandemic influenza vaccine available for ordering.

Allocating: Process of dividing available vaccine among CDC’s PHEP awardees or among registered pandemic influenza vaccine providers and facilities within an awardee’s jurisdiction.

Critical infrastructure personnel (CIP): The full list of CIP is defined in Guidance on Allocating and Targeting Pandemic Influenza Vaccine; U.S. Department of Health and Human Services (HHS)/U.S. Department of Homeland Security (DHS); 2008 Guidance on Allocating and Targeting Pandemic Influenza Vaccine
 
 
Distribution: The process of transporting pandemic influenza vaccine from one location to  another.

Enrollment: The process of enabling registered healthcare providers and facilities to legally provide pandemic influenza vaccine.

Ordering: Process of requesting pandemic influenza vaccine from either the federal, state, city, or local government. Orders can be placed against an allocation or independent of allocation.

Non-pharmaceutical interventions (NPIs): Those interventions that can mitigate transmission of influenza and do not involve medical countermeasures. NPIs include voluntary home isolation, school closures, respiratory etiquette, hand hygiene, and routine cleaning of frequently touched surfaces and objects.  

Peak vaccine administration capacity: The highest rate at which a jurisdiction is able to provide pandemic influenza vaccine to its population; CDC recommends a peak vaccine administration capacity of at least 10% of the population per week.  

Point of dispensing (POD) / mass vaccination clinic: Location for dispensing medical countermeasures, specifically for vaccine, during an influenza pandemic response.  Located in a public or private space, this clinic is designed to vaccinate a large group of persons over a short time period. The POD or clinic might target the entire population or people in specific priority or high-risk groups. Public and/or private entities can manage a POD or clinic.

Closed POD: Point of dispensing/vaccination clinic closed to the general public and open only to a specific group (e.g., staff of a participating business or healthcare personnel in a specific hospital).

Open POD: Point of dispensing/vaccination clinic open to the general public, specifically to provide vaccine, during an influenza pandemic response.

Recruitment: The process of soliciting healthcare providers and facilities interested in and willing to provide pandemic influenza vaccine.

Registration: The submission of required information, similar to an application, by healthcare providers or facilities interested in providing pandemic influenza vaccinations.  

Retail-based clinics: Non-pharmacy businesses that sell retail products (e.g., Walmart, Target) and serve as PODs/mass vaccination clinics.  

School-located vaccination clinics: Vaccination clinics that target students and are typically held on school grounds.

Public reporting burden of this collection of information is estimated to average 30 minutes per response, including time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid Office of Management and Budget control number. Send comments regarding this burden estimate, or any other aspect of this information collection, including suggestions for reducing this burden to CDC/Agency for Toxic Substance and Disease Registry Information Collection Review Office, 1600 Clifton Road NE, MS D-74, Atlanta, Georgia 30333; Attention: PRA (0920-0879).



(End of Page 1)

Section VI: Public Information and Communication

Goal: Effectively reach key and diverse audiences with timely, accurate, and credible information about the public health threat; recommended health protection actions; and inform audiences about government actions being taken to respond to the influenza pandemic.  

Assumptions:
• The first report of a suspected case of pandemic influenza in the United States may come from news or social media channels.
• Incomplete information, misinformation, rumors, and misconceptions may circulate among the public. People may take actions based on this misinformation. 
• Local partners, news media, policy makers, the general public, and other audiences will have immediate and ongoing demands for information and products. These demands will place significant pressure on CDC and the state(s) to provide facts and messaging quickly.
• CDC’s guidance and recommendations will change as we learn more about the evolving situation.
• CDC guidance and recommendations may differ from local guidance.

(End of Page 2)

Section VI: Public Information and Communication

Please select your jurisdiction:

Alabama

Alaska

American Samoa

Arizona

Arkansas

California

Chicago

Colorado

Commonwealth of the Northern Mariana Islands

Connecticut

Delaware

Federated States of Micronesia

Florida

Georgia

Guam

Hawaii

Idaho

Illinois

Indiana

Iowa

Kansas

Kentucky

Los Angeles County

Louisiana

Maine

Maryland

Massachusetts

Michigan

Minnesota

Mississippi

Missouri

Montana

Nebraska

Nevada

New Hampshire

New Jersey

New Mexico

New York

New York City

North Carolina

North Dakota

Ohio

Oklahoma

Oregon

Pennsylvania

Puerto Rico

Republic of Palau

Republic of the Marshall Islands

Rhode Island

South Carolina

South Dakota

Tennessee

Texas

U.S. Virgin Islands

Utah

Vermont

Virginia

Washington

Washington, DC

West Virginia

Wisconsin

Wyoming



Please select your position:

PHEP Director

Public Information Officer

Public Information Staff

Other (please specify) ____________________

(End of Page 3)

Section VI: Public Information and Communication

1. Has your jurisdiction developed a comprehensive communications plan for novel influenza outbreaks or a pandemic that includes any of the following elements (please check all that apply)?


Target audience

Goals and objectives

Strategies

Tactics

Channels of communication (e.g., mainstream media, social media, partners, etc.)

Evaluation

No comprehensive communications plan

Comprehensive communications plan in development

Other (Please specify) ____________________



2. Does your communications plan include promotion of the following? Please check all that apply:


Vaccine clinics

Availability of antiviral medications

Non-pharmaceutical interventions (e.g., hand-washing, staying home when sick, wearing face masks)

Other mitigation activities (please specify) ____________________



3. Has your jurisdiction identified key staff to serve as spokespeople during a novel influenza outbreak or pandemic?

Yes

No



4. Has staff been provided with media/spokespeople training so they can effectively communicate important information to the news media and other audiences?

Yes

No



5. Has your jurisdiction developed a process or protocol for clearing the release of public information that is agreed upon by appropriate subject matter experts?

Yes

No



6. Has your jurisdiction tested a process or protocol for clearing the release of public information that is agreed upon by appropriate subject matter experts?

Yes

No



7. Which of the following two-way communication channels has your jurisdiction established for the purpose of communicating with staff, partner organizations, the media, the general public, and other key audiences? Please check all that apply: 
 

Conference call lines

Web conferencing capability

Hotlines

None

Other (please specify) ____________________



8. Which of the following has your jurisdiction included in a specific plan to reach vulnerable and at-risk populations and those whose primary language is not English (please check all that apply)? 

Have not developed a specific plan to reach vulnerable and at-risk populations and those whose primary language is not English

Partnerships with agencies serving these populations

Strategies for reaching these populations

Identification of the most common non-English languages spoken in your jurisdiction

Process for securing translation services for those non-English languages

Other (please specify) ____________________



(End of Page 4)



File Typeapplication/msword
File TitleL1. Section VI_Public Information and Communication
AuthorNacalaban, Olga
Last Modified ByCDC User
File Modified2015-03-25
File Created2015-03-20

© 2024 OMB.report | Privacy Policy